leflunomide has been researched along with Rhabdomyolysis in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamski, H | 1 |
Lopez, L | 1 |
Polard, E | 1 |
Chevrant-Breton, J | 1 |
Dupuy, A | 1 |
Rivarola de Gutierrez, E | 1 |
Abaca, H | 1 |
2 other studies available for leflunomide and Rhabdomyolysis
Article | Year |
---|---|
Photodistributed eruption with rhabdomyolisis due to leflunomide.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Le | 2011 |
Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Eruptions; Fema | 2004 |